Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Sunitinib(Sutent)

Sunitinib is a Broad-spectrum antitumor agents.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：166
Palbociclib(Ibrance)

Applicable for the treatment of adult patients with advanced or metastatic breast cancer who are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：225
Ribociclib(Kisqali)

Ribociclib is a Broad-spectrum antitumor agents.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：249
Anagrelide(Agrylin)

Thrombocythemia【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：194
Binimetinib(Mektovi)

Binimetinib can be used for the treatment of melanoma and non-small cell lung cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：207
Elacestrant(Orserdu)

Elacestrant is suitable for the treatment of specific types of breast cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：176
Resmetirom(Rezdiffra)

Non-cirrhosis non-alcoholic steatohepatitis【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：154
Futibatinib(Lytgobi)

Carcinoma of bile duct【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：258
Tazemetostat(Tazverik)

Tazemetostat is a Broad-spectrum antitumor agents.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：171
Abemaciclib(Verzenios)

Indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early-stage, late-stage, or metastatic breast cancer in adul···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：41
Acalabrutinib(Calquence)

It is indicated for the treatment of adult patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：120
Ambrisentan(Volibris)

It is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1), which can improve exercise capacity, delay clinical deterioration, or b···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：47

home page previous 47 47/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More